Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Total Debt (2020 - 2025)

Oncology Institute's Total Debt history spans 6 years, with the latest figure at $77.4 million for Q4 2025.

  • For Q4 2025, Total Debt fell 16.89% year-over-year to $77.4 million; the TTM value through Dec 2025 reached $77.4 million, down 16.89%, while the annual FY2025 figure was $77.4 million, 16.89% down from the prior year.
  • Total Debt reached $77.4 million in Q4 2025 per TOI's latest filing, up from $76.2 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $93.1 million in Q4 2024 to a low of $183000.0 in Q4 2021.
  • Average Total Debt over 5 years is $77.6 million, with a median of $82.1 million recorded in 2023.
  • Peak YoY movement for Total Debt: tumbled 98.47% in 2021, then skyrocketed 43955.19% in 2022.
  • A 5-year view of Total Debt shows it stood at $183000.0 in 2021, then surged by 43955.19% to $80.6 million in 2022, then grew by 7.7% to $86.8 million in 2023, then rose by 7.26% to $93.1 million in 2024, then dropped by 16.89% to $77.4 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Total Debt are $77.4 million (Q4 2025), $76.2 million (Q3 2025), and $75.0 million (Q2 2025).